October 21, 2019
GET A RELIABLE, COMPREHENSIVE INVENTORY OF RESIDUAL
HCP IN YOUR PROCESS INTERMEDIATES AND FINAL DRUG SUBSTANCE
You might also be interested by
Press Releases
CellCarta expands it proteomics portfolio with the acquisition of next-generation immuno-MRM assays from Precision Assays
May 19, 2022
Proteomics/Mass Spectrometry
More infoBrochures
High Performance Technologies for Cytokine Measurement
November 8, 2021
Immune Monitoring
More info